Cardiac sarcoidosis and coronary artery disease: a two-hit mechanism to left ventricular dysfunction (or is it)?
James C. Hansen(Weber State University), John F. Beshai(MACOM (United States)), Joshua D. Moss(MACOM (United States)), Amit R. Patel(University of Virginia), Hemal M. Nayak(University of Chicago), Nadera Sweiss(University of Illinois Chicago)
PubMed
November 25, 2013
Cited by 2
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Racial Difference in Sarcoidosis Mortality in the United States
|CHEST Journal|2014|251
Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension
|Journal of Cardiovascular Magnetic Resonance|2012|222
Transthoracic 3D Echocardiographic Left Heart Chamber Quantification Using an Automated Adaptive Analytics Algorithm
|JACC. Cardiovascular imaging|2016|220